ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

FRANCISCO RIVERA M.D.

STREET 778 KM. 0.9 PASARELL PABELLON DE SERVICIOS

Comerio | Puerto Rico | 00782

(787) 875-3136

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,422Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1479

$920K Total Retail Price of All Prescriptions

Rank: 6 out of 1479

600 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 600 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

9% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 14,784 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 868 604 1 1
METFORMIN HCL 752 444 2 2
GABAPENTIN 554 350 3 5
LEVOTHYROXINE SODIUM 536 372 4 9
RANITIDINE HCL 491 348 5 4
AMLODIPINE BESYLATE 483 340 6 6
ZOLPIDEM TARTRATE 446 256 7 23
GLIMEPIRIDE 442 260 8 21
ATORVASTATIN CALCIUM 417 260 9 41
OMEPRAZOLE 403 208 10 7
HYDROCHLOROTHIAZIDE 399 257 11 10
TRAMADOL HCL-ACETAMINOPHEN 387 262 12 18
ENALAPRIL MALEATE 376 235 13 3
PANTOPRAZOLE SODIUM 376 200 13 48
LOSARTAN POTASSIUM 372 198 15 8
LOSARTAN-HYDROCHLOROTHIAZIDE 351 237 16 14
SYNTHROID 285 185 17 12
FUROSEMIDE 284 170 18 15
LEVOXYL 272 220 19 44
DICLOFENAC POTASSIUM 266 155 20 29
SURE COMFORT 265 185 21 58
ALENDRONATE SODIUM 255 206 22 19
METOPROLOL SUCCINATE 252 143 23 51
TAMSULOSIN HCL 246 192 24 36
ATENOLOL 241 166 25 11
DEXAMETHASONE SODIUM PHOSPHATE 228 130 10 26 140
LISINOPRIL 223 164 27 16
INSULIN SYRINGE 223 141 27 30
LEVOFLOXACIN 208 129 29 115
METHYLPREDNISOLONE 206 144 30 102
HUMULIN 70-30 206 131 30 43
METOPROLOL TARTRATE 198 113 32 17
DEXAMETHASONE 197 128 33 60
TRAMADOL HCL 195 133 34 20
RAMIPRIL 193 95 35 63
SERTRALINE HCL 190 128 36 38
GLIPIZIDE 186 81 37 13
CARVEDILOL 181 132 38 32
DOXAZOSIN MESYLATE 181 143 38 33
CLOTRIMAZOLE-BETAMETHASONE 164 93 40 39
FAMOTIDINE 163 93 41 47
MELOXICAM 158 106 42 90
ASPIRIN EC 157 122 43 24
PROAIR HFA 155 66 44 80
CLOPIDOGREL 149 134 45 46
LANSOPRAZOLE 145 84 46 92
HUMALOG MIX 75-25 139 96 47 154
IRBESARTAN 138 103 48 78
LANTUS 138 91 48 35
NALBUPHINE HCL 136 0 10 50 199
AMLODIPINE BESYLATE-BENAZEPRIL 133 84 51 54
PLAVIX 132 111 52 52
AZITHROMYCIN 132 73 52 25
SPIRONOLACTONE 122 91 54 94
TIZANIDINE HCL 122 70 54 134
HUMULIN N 119 77 56 42
LYRICA 119 39 56 99
PRAVASTATIN SODIUM 116 76 58 27
SINGULAIR 113 78 59 74
DONEPEZIL HCL 112 93 60 45
NIFEDIPINE ER 111 66 61 121
VERAPAMIL ER 110 70 62 34
ENDOCET 109 26 S2 63 148
GLYBURIDE 108 80 R 64 55
AMITRIPTYLINE HCL 104 69 R 65 106
CYMBALTA 102 58 66 159
FLUTICASONE PROPIONATE 92 46 67 64
OXYCODONE-ACETAMINOPHEN 92 12 S2 67 70
ISOSORBIDE MONONITRATE ER 91 80 69 31
EVISTA 90 79 70 79
MECLIZINE HCL 90 76 70 50
NABUMETONE 89 40 72 22
LEVOCETIRIZINE DIHYDROCHLORIDE 82 45 73 138
HUMALOG MIX 50-50 81 13 74 275
CIPROFLOXACIN HCL 81 45 74 26
TRICOR 80 57 76 178
NAMENDA 76 76 77 69
ADVAIR DISKUS 75 60 78 104
QUINAPRIL HCL 72 37 79 136
GLIPIZIDE-METFORMIN 71 47 80 192
PENTOXIFYLLINE 71 45 80 40
WARFARIN SODIUM 70 58 82 83
ACETAMINOPHEN-CODEINE 70 21 S3 82 214
FLUCONAZOLE 69 32 84 197
CLONIDINE HCL 69 38 84 71
HYDRALAZINE HCL 69 66 84 139
ORPHENADRINE CITRATE 68 12 R 87 118
PRANDIN 64 38 88 226
DILTIAZEM 24HR CD 63 48 89 156
TRIAMTERENE-HCTZ 63 38 89 195
FEXOFENADINE HCL 60 45 91 112
AVAPRO 60 36 91 114
QUETIAPINE FUMARATE 59 20 93 108
PROVENTIL HFA 58 30 94 198
RISPERIDONE 58 42 94 88
TRILIPIX 58 23 94 166
NAPROXEN 58 33 94 57
HUMALOG 57 46 98 169
ASPIR-LOW 57 47 98 124
DIPHENHYDRAMINE HCL 56 39 R 100 137
ETODOLAC 55 27 101 75
FINASTERIDE 54 54 102 84
OXYBUTYNIN CHLORIDE 54 54 102 257
FENOFIBRATE 53 41 104 37
PREDNISOLONE ACETATE 52 36 105 266
VYTORIN 51 37 106 170
CLOBETASOL PROPIONATE 51 30 106 133
BETAMETHASONE DIPROPIONATE 50 21 108 91
IRBESARTAN-HYDROCHLOROTHIAZIDE 50 38 108 270
CILOSTAZOL 50 34 108 65
HYDROCODONE-ACETAMINOPHEN 50 43 S3 108 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.